Impact of cytogenetic abnormalities on the management of skull base chordomas: Clinical article

Journal of Neurosurgery

Volumn 110, Issue 4, 2009, Pages 715-724

  Almefty, Kaith K ^a   Pravdenkova, Svetlana ^a   Sawyer, Jeffrey R ^a   Al Mefty, Ossama ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Chordoma; Cytogenetic study; Karyotype

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CHORDOMA; CHROMOSOME 12; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FEMALE; FOLLOW UP; GASTRIC BANDING; HUMAN; INCIDENCE; KARYOTYPE; KARYOTYPING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SKULL BASE CHORDOMA; SKULL BASE TUMOR; SURVIVAL; SURVIVAL TIME; TUMOR GROWTH; TUMOR RECURRENCE; GENETICS; MORTALITY;

ADULT; CHORDOMA; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; KARYOTYPING; MALE; NEOPLASM RECURRENCE, LOCAL; SKULL BASE NEOPLASMS;

EID: 65649118280     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.9.JNS08285     Document Type: Article

References (40)

1. Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M: Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer 110:2457-2467, 2007 (Pubitemid 350174931)
2. Bayrakli F, Guney I, Kilic T, Ozek M, Pamir MN: New candidate chromosomal regions for chordoma development. Surg Neurol 68:425-430, 2007 (Pubitemid 47464455)
3. Brandal P, Bjerkehagen B, Danielsen H, Heim S: Chromosome 7 abnormalities are common in chordomas. Cancer Genet Cytogenet 160:15-21, 2005 (Pubitemid 40798131)
4. Bridge JA, Pickering D, Neff JR: Cytogenetic and molecular cytogenetic analysis of sacral chordoma. Cancer Genet Cytogenet 75:23-25, 1994 (Pubitemid 24241105)
5. Buonamici L, Roncaroli F, Fioravanti A, Losi L, Van den Berghe H, Calbucci F, et al: Cytogenetic investigation of chordomas of the skull. Cancer Genet Cytogenet 112:49-52, 1999
6. Butler MG, Dahir GA, Hedges LK, Juliao SF, Sciadini MF, Schwartz HS: Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet 85:51-57, 1995
7. Colli B, Al-Mefty O: Chordomas of the craniocervical junction: follow-up review and prognostic factors. J Neurosurg 95:933-943, 2001 (Pubitemid 33123849)
8. Dalpra L, Malgara R, Miozzo M, Riva P, Volonte M, Larizza L, et al: First cytogenetic study of a recurrent familial chordoma of the clivus. Int J Cancer 81:24-30, 1999 (Pubitemid 29124191)
9. DeBoer JM, Neff JR, Bridge JA: Cytogenetics of sacral chordoma. Cancer Genet Cytogenet 64:95-96, 1992
10. Deniz ML, Kilic T, Almaata I, Kurtkaya O, Sav A, Pamir MN: Expression of growth factors and structural proteins in chordomas: basic fibroblast growth factor, transforming growth factor alpha, and fibronectin are correlated with recurrence. Neurosurgery 51:753-760, 2002 (Pubitemid 36331070)
11. Eisenberg MB, Woloschak M, Sen C, Wolfe D: Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. Surg Neurol 47:156-161, 1997 (Pubitemid 27074169)
12. Fasig JH, Dupont WD, LaFleur BJ, Olson SJ, Cates JM: Immunohistochemical analysis of receptor tyrosine kinase signal transduction activity in chordoma. Neuropathol Appl Neurobiol 34:95-104, 2008
13. Gay E, Sekhar LN, Rubinstein E, Wright DC, Sen C, Janecka IP, et al: Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery 36:887-897, 1995
14. Hallor KH, Staaf J, Jonsson G, Heidenblad M, Vult von Steyern F, Bauer HC, et al: Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation. Br J Cancer 98:434-442, 2008 (Pubitemid 351161241)
15. Harsh GR IV, Janecka I, Mankin H, Ojemann R, Suit H, McKenna M: Chordomas and chondrosarcomas of the skull base, in Kaye AH, Laws ER (eds): Brain Tumors, ed 2. London: Churchill Livingstone, 2001, pp 857-868
16. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428, 2002
17. Kelley MJ, Korczak JF, Sheridan E, Yang X, Goldstein AM, Parry DM: Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. Am J Hum Genet 69:454-460, 2001 (Pubitemid 32695218)
18. Klingler L, Trammell R, Allan DG, Butler MG, Schwartz HS: Clonality studies in sacral chordoma. Cancer Genet Cytogenet 171:68-71, 2006
19. Knudsen ES, Sexton CR, Mayhew CN: Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Curr Mol Med 6:749-757, 2006
20. Kuzniacka A, Mertens F, Strombeck B, Wiegant J, Mandahl N: Combined binary ratio labeling fluorescence in situ hybridization analysis of chordoma. Cancer Genet Cytogenet 151:178-181, 2004 (Pubitemid 38692819)
21. Lee WH: The molecular basis of cancer suppression by the retinoblastoma gene. Princess Takamatsu Symp 20:159-170, 1989
22. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 396:643-649, 1998
23. Longoni M, Orzan F, Stroppi M, Boari N, Mortini P, Riva P: Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study. Neuro-oncol 10:52-60, 2008 (Pubitemid 351250900)
24. Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA: Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 15:43-49, 2005 (Pubitemid 40018527)
25. Miozzo M, Dalpra L, Riva P, Volonta M, Macciardi F, Pericotti S, et al: A tumor suppressor locus in familial and sporadic chordoma maps to 1p36. Int J Cancer 87:68-72, 2000 (Pubitemid 30368417)
26. Mitelman F, Johansson B, Mertens F (eds): Mitelman Database of Chromosome Aberrations in Cancer. Bethesda, MD: National Cancer Institute, 2008. (http://cgap.nci.nih.gov/Chromosomes/ Mitelman) [Accessed 9 October 2008]
27. Naka T, Boltze C, Kuester D, Schulz TO, Schneider-Stock R, Kellner A, et al: Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression. Cancer 104:1255-1263, 2005 (Pubitemid 41278961)
28. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih I, Vogelstein B, et al: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A 99:16226-16231, 2002 (Pubitemid 35462777)
29. Pallini R, Maira G, Pierconti F, Falchetti ML, Alvino E, Cimino- Reale G, et al: Chordoma of the skull base: predictors of tumor recurrence. J Neurosurg 98:812-822, 2003 (Pubitemid 36396784)
30. Riva P, Crosti F, Orzan F, Dalpra L, Mortini P, Parafioriti A, et al: Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer 107:493-497, 2003 (Pubitemid 37266472)
31. Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 145:1-30, 2003 (Pubitemid 36926284)
32. Sawyer JR, Husain M, Al-Mefty O: Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors? Neurosurg Focus 10(3):E6, 2001
33. Scheil S, Bruderlein S, Liehr T, Starke H, Herms J, Schulte M, et al: Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer 32:203-211, 2001 (Pubitemid 32953974)
34. Shaffer LG, Tommerup N (eds): ISCN 2005. An International System for Human Cytogenetic Nomenclature. Basel: Karger, 2005
35. Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE: Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 60:1211-1216, 2000
36. Tallini G, Dorfman H, Brys P, Dal Cin P, De Wever I, Fletcher CD, et al: Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the chromosomes and morphology (CHAMP) collaborative study group. J Pathol 196:194-203, 2002 (Pubitemid 34110901)
37. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GP, et al: Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas. Clin Cancer Res 12:6920-6928, 2006 (Pubitemid 44974484)
38. Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med 10:789-799, 2004 (Pubitemid 39070849)
39. Wilkens L, Flemming P, Gebel M, Bleck J, Terkamp C, Wingen L, et al: Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci U S A 101:1309-1314, 2004 (Pubitemid 38182685)
40. Zheng L, Lee WH: Retinoblastoma tumor suppressor and genome stability. Adv Cancer Res 85:13-50, 2002